Welcome

FazaClo® (clozapine, USP) is a unique orally disintegrating tablet formulation of clozapine. FazaClo is an antipsychotic drug indicated for the management of severely ill schizophrenic patients who fail to respond to standard treatments. FazaClo also is indicated for reduction in the risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorders. FazaClo is supported by a national sales infrastructure as well as a field–based team of Clinical Compliance Liaisons. In addition, FazaClo has a patient registry team, who provide 24/7 assistance to healthcare professionals and patients.